Company / Operating Margin
TREACE MEDICAL CONCEPTS, INC. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-27.5%
FY2025
5-year range
-27.5% / 1.5%
FY2021-FY2025
Trend
-11.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has declined for 3 consecutive years, from 1.5% in FY2022 to -27.5% in FY2025.
Based on SEC 10-K filings.
-27.5% in FY2025 with a 3-year CAGR of -29.0%.
Declined from -17.5% to -27.5% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -29.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s operating margin has declined for 3 consecutive years.
- In FY2025, operating margin decreased 11.8% year-over-year.
- Peak operating margin was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -27.5% | -11.8% |
| FY2024 | -24.6% | -40.5% |
| FY2023 | -17.5% | -1273.8% |
| FY2022 | 1.5% | +116.6% |
| FY2021 | -9.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026